SG11201401591WA - Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone - Google Patents
Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanoneInfo
- Publication number
- SG11201401591WA SG11201401591WA SG11201401591WA SG11201401591WA SG11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA SG 11201401591W A SG11201401591W A SG 11201401591WA
- Authority
- SG
- Singapore
- Prior art keywords
- methanone
- thiomorpholinyl
- dioxo
- isoxazolyl
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11185993 | 2011-10-20 | ||
PCT/EP2012/070522 WO2013057124A1 (en) | 2011-10-20 | 2012-10-17 | Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201401591WA true SG11201401591WA (en) | 2014-05-29 |
Family
ID=47019027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201401591WA SG11201401591WA (en) | 2011-10-20 | 2012-10-17 | Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone |
Country Status (20)
Country | Link |
---|---|
US (2) | US8785435B2 (en) |
EP (1) | EP2768821B1 (en) |
JP (1) | JP5918856B2 (en) |
KR (1) | KR20140079503A (en) |
CN (1) | CN103889971B (en) |
AR (1) | AR088359A1 (en) |
AU (1) | AU2012318294B2 (en) |
BR (1) | BR112014009288A8 (en) |
CA (1) | CA2850441A1 (en) |
DK (1) | DK2768821T3 (en) |
ES (1) | ES2606547T3 (en) |
HK (1) | HK1193611A1 (en) |
HU (1) | HUE030298T2 (en) |
IL (1) | IL231532A0 (en) |
MX (1) | MX341492B (en) |
PL (1) | PL2768821T3 (en) |
RU (1) | RU2618524C2 (en) |
SG (1) | SG11201401591WA (en) |
SI (1) | SI2768821T1 (en) |
WO (1) | WO2013057124A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2792360A1 (en) | 2013-04-18 | 2014-10-22 | IP Gesellschaft für Management mbH | (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV |
BR112020004116A2 (en) | 2017-08-28 | 2020-09-01 | University Of Maryland, Baltimore | new modulators of the type a gamma aminobutyric acid receptor for mood disorders |
PE20210555A1 (en) | 2018-06-13 | 2021-03-17 | Hoffmann La Roche | NEW DERIVATIVES OF ISOXAZOLYL ETHER AS PAM FROM GABA TO ALFA5 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE352505C (en) | 1918-03-01 | 1922-04-27 | Metallbank | Method for processing ammonia slag |
DE3525205A1 (en) | 1984-09-11 | 1986-03-20 | Hoechst Ag, 6230 Frankfurt | PLANT PROTECTIVE AGENTS BASED ON 1,2,4-TRIAZOLE DERIVATIVES AND NEW DERIVATIVES OF 1,2,4-TRIAZOLE |
GB9808663D0 (en) | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic agents |
ES2255294T3 (en) | 1998-08-07 | 2006-06-16 | Chiron Corporation | ISOXAZOL DERIVATIVES REPLACED AS MODULATORS OF THE STROGEN RECEPTOR. |
US6297256B1 (en) | 1999-06-15 | 2001-10-02 | Neurogen Corporation | Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands |
US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
IT1314191B1 (en) | 1999-10-18 | 2002-12-06 | Recordati Chem Pharm | ISOSSAZOLCARBOSSAMIDIC DERIVATIVES |
AU1481701A (en) | 1999-11-12 | 2001-06-06 | Neurogen Corporation | Bicyclic and tricyclic heteroaromatic compounds |
PA8535601A1 (en) | 2000-12-21 | 2002-11-28 | Pfizer | BENZIMIDAZOL AND PIRIDILIMIDAZOL DERIVATIVES AS LIGANDOS FOR GABAA |
GB0108475D0 (en) | 2001-04-04 | 2001-05-23 | Merck Sharp & Dohme | New compounds |
EA005934B1 (en) | 2001-07-05 | 2005-08-25 | Х. Лундбекк А/С | Substituted anilinic piperidines as mch selective antagonists |
DE60131967D1 (en) | 2001-08-13 | 2008-01-31 | Phenex Pharmaceuticals Ag | Nr1h4 nuclear receptor binding compounds |
ES2299618T3 (en) | 2001-11-20 | 2008-06-01 | Eli Lilly And Company | BETA-3-ADRENERGIC AGONISTS. |
GB0128160D0 (en) | 2001-11-23 | 2002-01-16 | Merck Sharp & Dohme | Novel compounds |
GB0128499D0 (en) | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
EP1562915A1 (en) | 2002-11-22 | 2005-08-17 | SmithKline Beecham Corporation | Farnesoid x receptor agonists |
GB0318447D0 (en) | 2003-08-05 | 2003-09-10 | Merck Sharp & Dohme | Therapeutic agents |
RU2408589C2 (en) | 2004-05-14 | 2011-01-10 | Айрм Ллк | Compounds and compositions as modulators of ppar-receptors activated by peroxisome proliferator |
MXPA06013603A (en) | 2004-06-01 | 2007-02-08 | Hoffmann La Roche | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists. |
JP2008502687A (en) | 2004-06-14 | 2008-01-31 | タケダ サン ディエゴ インコーポレイテッド | Kinase inhibitor |
MX2007003648A (en) | 2004-10-01 | 2007-06-11 | Hoffmann La Roche | Hexafluoroisopropanol substituted ether derivatives. |
WO2006044617A1 (en) | 2004-10-15 | 2006-04-27 | The Scripps Research Institute | Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
US20070060589A1 (en) | 2004-12-21 | 2007-03-15 | Purandare Ashok V | Inhibitors of protein arginine methyl transferases |
WO2006095822A1 (en) | 2005-03-11 | 2006-09-14 | Ono Pharmaceutical Co., Ltd. | Sulfonamide compound and pharmaceutical thereof |
WO2007002635A2 (en) | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
EP1904338B1 (en) | 2005-07-20 | 2011-11-09 | Prospective Concepts AG | Pneumatic cushion structure |
EP1931661B1 (en) | 2005-09-19 | 2008-11-19 | F.Hoffmann-La Roche Ag | Isoxazolo derivatives as gaba a alpha5 inverse agonists |
JP2009511533A (en) | 2005-10-11 | 2009-03-19 | エフ.ホフマン−ラ ロシュ アーゲー | Isoxazole derivatives |
WO2007052843A1 (en) | 2005-11-04 | 2007-05-10 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof |
ATE507222T1 (en) * | 2005-11-30 | 2011-05-15 | Hoffmann La Roche | 1,1-DIOXO-THIOMORPHOLINYL-INDOLYL-METHANONE DERIVATIVES FOR USE AS H3 MODULATORS |
ATE526318T1 (en) | 2005-12-19 | 2011-10-15 | Glaxosmithkline Llc | FARNESOID-X RECEPTOR AGONISTS |
WO2007071476A1 (en) * | 2005-12-20 | 2007-06-28 | International Business Machines Corporation | Method, system and computer program for distributing software products based on an e-mail service |
JP5301286B2 (en) | 2006-02-03 | 2013-09-25 | イーライ リリー アンド カンパニー | Compounds and methods for modulating FX receptors |
JP2007230909A (en) | 2006-03-01 | 2007-09-13 | Univ Of Tokyo | Substituted isoxazole derivative |
EP2029559B1 (en) | 2006-05-31 | 2009-08-05 | F. Hoffmann-Roche AG | Aryl-4-ethynyl-isoxazole derivatives |
EP1894924A1 (en) | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
EP1894928A1 (en) | 2006-08-29 | 2008-03-05 | PheneX Pharmaceuticals AG | Heterocyclic fxr binding compounds |
WO2008130951A1 (en) | 2007-04-17 | 2008-10-30 | Bristol-Myers Squibb Company | Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
US7618973B2 (en) | 2007-12-04 | 2009-11-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyrazine derivatives |
AU2008333326B2 (en) | 2007-12-04 | 2013-05-30 | F. Hoffmann-La Roche Ag | Isoxazolo-pyridine derivatives |
-
2012
- 2012-10-12 US US13/650,159 patent/US8785435B2/en active Active
- 2012-10-17 BR BR112014009288A patent/BR112014009288A8/en not_active IP Right Cessation
- 2012-10-17 SI SI201230792A patent/SI2768821T1/en unknown
- 2012-10-17 HU HUE12772789A patent/HUE030298T2/en unknown
- 2012-10-17 PL PL12772789T patent/PL2768821T3/en unknown
- 2012-10-17 SG SG11201401591WA patent/SG11201401591WA/en unknown
- 2012-10-17 CA CA2850441A patent/CA2850441A1/en not_active Abandoned
- 2012-10-17 CN CN201280051089.3A patent/CN103889971B/en active Active
- 2012-10-17 AR ARP120103860A patent/AR088359A1/en unknown
- 2012-10-17 JP JP2014536209A patent/JP5918856B2/en active Active
- 2012-10-17 MX MX2014004678A patent/MX341492B/en active IP Right Grant
- 2012-10-17 ES ES12772789.9T patent/ES2606547T3/en active Active
- 2012-10-17 RU RU2014118968A patent/RU2618524C2/en not_active IP Right Cessation
- 2012-10-17 WO PCT/EP2012/070522 patent/WO2013057124A1/en active Application Filing
- 2012-10-17 AU AU2012318294A patent/AU2012318294B2/en not_active Ceased
- 2012-10-17 EP EP12772789.9A patent/EP2768821B1/en active Active
- 2012-10-17 DK DK12772789.9T patent/DK2768821T3/en active
- 2012-10-17 KR KR1020147013555A patent/KR20140079503A/en active Search and Examination
-
2014
- 2014-03-13 IL IL231532A patent/IL231532A0/en active IP Right Grant
- 2014-06-04 US US14/295,535 patent/US8975397B2/en active Active
- 2014-07-09 HK HK14106993.8A patent/HK1193611A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR088359A1 (en) | 2014-05-28 |
AU2012318294A1 (en) | 2013-05-09 |
RU2014118968A (en) | 2015-11-27 |
JP2014530832A (en) | 2014-11-20 |
DK2768821T3 (en) | 2017-01-23 |
AU2012318294B2 (en) | 2015-10-01 |
HUE030298T2 (en) | 2017-04-28 |
RU2618524C2 (en) | 2017-05-04 |
IL231532A0 (en) | 2014-04-30 |
ES2606547T3 (en) | 2017-03-24 |
CA2850441A1 (en) | 2013-04-25 |
BR112014009288A8 (en) | 2020-04-22 |
SI2768821T1 (en) | 2017-01-31 |
BR112014009288A2 (en) | 2017-06-13 |
CN103889971B (en) | 2016-08-31 |
WO2013057124A1 (en) | 2013-04-25 |
EP2768821B1 (en) | 2016-11-16 |
NZ622215A (en) | 2016-06-24 |
US20140329806A1 (en) | 2014-11-06 |
MX341492B (en) | 2016-08-23 |
HK1193611A1 (en) | 2014-09-26 |
US20130172329A1 (en) | 2013-07-04 |
CN103889971A (en) | 2014-06-25 |
US8975397B2 (en) | 2015-03-10 |
US8785435B2 (en) | 2014-07-22 |
JP5918856B2 (en) | 2016-05-18 |
KR20140079503A (en) | 2014-06-26 |
PL2768821T3 (en) | 2017-05-31 |
MX2014004678A (en) | 2014-05-28 |
EP2768821A1 (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1196371A1 (en) | Substituted imidazopyridinyl aminopyridine compounds | |
IL235745A (en) | 2-aminopyridine derivatives | |
EP2671582A4 (en) | Ring-fused heterocyclic derivative | |
ZA201201125B (en) | Pyridin-4-yl derivatives | |
EP2703394A4 (en) | Novel 3-hydroxyisothiazole 1-oxide derivative | |
HK1188145A1 (en) | Novel fused pyridine compounds as casein kinase inhibitors | |
HK1202288A1 (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives 2---35- | |
HK1198586A1 (en) | 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives 6--56--2h-[14]-3- | |
IL232717A0 (en) | 3-cyanoaryl-1h-pyrrolo[2,3-b]pyridine derivatives | |
EP2524917A4 (en) | Fused pyridine derivatives | |
PT2771327T (en) | Novel pyrazine derivatives | |
EP2668186A4 (en) | Pharmaceutical composition comprising pyridone derivatives | |
EP2558094A4 (en) | Pyridone derivatives | |
HK1187336A1 (en) | Pharmaceutical composition comprising pyridone derivatives | |
HK1193611A1 (en) | Solid forms of 1,1-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5- methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone (1l--4-)-[6-[[3(4-)-5--4-]]-3- ]- | |
AU2011901088A0 (en) | Door Track | |
GB201119592D0 (en) | Novel heteroaromatic Derivatives I |